Member Info for Newuncle

Bet Gerry wishes he had approached these guys for funding now, they sound like well informed and long term players:

About the investors:

SOSV is a global venture capital firm providing multi-stage investment to develop and scale our founders' big ideas for positive change. They also have the world's leading life science accelerator, IndieBio, and this investment represents a follow-on to their original pre-seed investment.

"Until now, trying to improve your skin's health and longevity has been a trial-and-error process, effectively doing chemistry experiments on your face," said Sean O'Sullivan, General Partner at SOSV. "With Sequential Skin, individuals now have the ability to zero in on the right treatments to quickly optimize skin health."

Metaplanet is an international early-stage investment firm based in Estonia making long-term bets on contrarians and leveraging the knowledge and network across sectors. They have invested in several leading healthcare companies, including some of the world's pioneering microbiome start-ups.

"With Sequential Skin, users can get an insightful and deep understanding of their skin state and what is needed to satisfy the demands that their surrounding environment and lifestyle poses on their skin. We were impressed by the Sequential Skin team and it seems one of the most promising personalized skincare companies currently on the market." - Rauno Miljand, Managing Partner, Metaplanet

Scrum Ventures is a seed-stage venture firm investing across a range of industries in the U.S. and Japan. Based in San Francisco with extensive experience and networks in both Silicon Valley and Japan, Scrum Ventures accelerates portfolio companies with global opportunities. Scrum Studio is a platform that connects global corporations with start-ups.

"Sequential Skin's upside to disrupt the personalized skincare space is significant. The product is easy to use, provides comprehensive insights and has value in D2C, clinical testing and B2B product validation use cases.

The company's at-home genetic and microbiome test kit has the potential to reach more consumers than any other personalized skincare company in the market. We are fortunate to partner with such a promising company and team." - Tak Miyata, Founder and General Partner, Scrum Ventures

Genedant is a venture capital firm that invests in emerging life science and technology which challenge conventional thinking of what is possible. The Singapore-based investment firm backs visionary thinkers, academics and clinicians who are never satisfied with the status quo and who are always seeking to improve on our current reality. Genedant takes long-term bets and risks on scientific and technological ideas even when they are at an early stage.

"The genetic and microbiome profile on everyone's skin is unique, much like a molecular fingerprint. What Sequential Skin brings is an ability to truly understand what our skin needs and make a personalised recomme

Now this is what makes this BB just in a different class to that one one on ADVFN. Here people can disagree but still discuss all aspects of DVRG. On ADVFN they just rip each other to shreds on a daily basis but that's what happens when trolls takeover a BB to the extent that ADVFN have allowed it, not just on DVRG but across many stocks.

I think that's why CR wanted a stand alone spin off company to go on the HK exchange was it not? That way they get their own version of DVRG for the Chinese Market?

Chesh,

Maybe but the messaging is virtually identical so the question remains is that good because others have also figured out there is a huge market for this or will consumers just pick the one that appeals the most (for whatever reason)? Or does it even matter anyway?

It almost sound like a carbon copy of what Gerry has been saying re STC but who actually said it first I wonder?

"We now have significant traction in assembling an extensive dataset on skin types from Asia, Europe and the US—a great chance for us to discover novel biomarkers for skin conditions in different populations," said Dr Oliver Worsley, CEO and cofounder.

The funding will significantly boost their IP portfolio, using their novel patch-based, skin analysis, to develop further tools to understand how your genetics, epigenetics and skin microbiome, affect health and disease.

Dr Albert Dashi, CSO and cofounder, added: "Our scope is to provide science to people and empower them with the right tools and knowledge so they make the right decision for the future of their skin health and well-being."

Dr Shan,

But we are not alone say, or as Gerry would say, having others doing the same thing simply validates what VVRG are trying to do with STC, you takes a look and decide for yourself if there is room for more than one player in a billion customer market?

https://uk.advfn.com/stock-market/stock-news/86253242/sequential-skin-raise-us-1-65m-in-oversubscribed

Be careful what you wish for, I saw shareholders over at ARB (Argo Blockchain) positively watering at the mouth when that was proposed and then implemented recently, pre US listing the SP was £1.40, currently it's £1.15.

DRShan,

This was an RNS from October 2020, I expect we will see this updated soo enough, subject to NDAs of course:

23 October 2020

DeepVerge PLC

("DeepVerge" or "the Company")

Reach Announcement

Comment on media coverage of detection of COVID-19 in UK Sewage

DeepVerge notes press commentary today that wastewater treatment sites in England, Wales and Scotland will start testing more sewage for coronavirus, with the aim of creating an early warning system to detect local outbreaks before they spread.
DeepVerge has been working with multiple universities and wastewater utilities since June this year on COVID-19 related projects. The Company is involved in many projects in the U.K., Ireland, Italy, Michigan, US, Shanghai, China and Japan.
Currently, in its Labskin laboratories in York, the Company is retrofitting Microtox equipment, from Modern Water plc (a company currently the subject of a recommended offer by DeepVerge) to install these projects.

Gerard Brandon CEO of DeepVerge Commented:

"The UK forms part of our COVID-19 real-time detection development strategy, cooperating with Modern Water plc supply chain and existing installation network in more than 60 countries. We continue to work with our EcoSystemOS consortium partners in the UK and overseas to bring advanced AI-based wastewater detection and pathogen identification projects from manual to automated real-time testing."

Is this the bottom?

12 month chart says yes.

Buy for 50% +++

DrShhan,

I think you give them far too much credit fwiw. I recall buying SKIN sub 1p and those derampers attacking it all the way down and back up again. They are just noise in the end and like having wasps at your picnic, very irritating but largely just annoying at the time. If anyone buys or sells based on postings on a BB without then doing their own due dilligence they only have themselves to blame.

Dr Shan,

Could be the bottom now based on the 12 month chart anyway it hit these levels back in November 2020 and then bounced back massively all the way to 36p in January.

Buy Buy Buy for 50% +++ gains short term if you believe the chart history will repeat itself.

Sharkfund,

Agree.

As for the sell up and go away advice from other posters, again just ignore them.

I do find it bizarre how posters complain when others are simply saying it as it is. It makes no real difference what posters put on BBs, it's what the company does or doesn't do that matters in the end. I mean I could post on here that DVRG will double or treble on the next RNS update which could be here is just a few days, does anyone really think that PIs would pile in on the back of that? No of course not, no more than any selling is down to postings on here.

Trills,

Until one or both of two things happen, yes.

I think that DVRG has just picked very poorly when comes to so called investors taking cheap placing stock who have clearly got a very different idea than Gerry has when it comes to selling their cheap shares for quick profits. They are the ones who have been proven to be unreliable partners and were only in to for a quick returns from their outlays, They may not be the rainbow chasers that Gerry tarred so many if us with as a description when people expressed their total frustration here having been very much led by social media postings from you know who for months prior. And yet Gerry still refuses to acknowledge his poor choices and instead just washes his hands and says the company can't control the daily share price (yes we get that but what he could have done locked in those so called investors or limited their options to sell or if had so much interest earlier this year from other backers he could have facilitated the transfer of shares between those parties as he belatedly stated a short while ago but of course it's too little too late now). The damage has been done and PI confidence is shot to bits here and elsewhere. There will come a point when the shares will rally but right now it's tough to call when you have larger players still dumping in volume every single day and no news from the company. A perfect storm as they say.

fwiw I am pretty sure the £10m is nailed on, set in stone, guaranteed for 2021 unless what Gerry has been saying only very recently is BS which I doubt very much indeed. As for the rest of what you say, as has been mentioned many many times NDA applies everywhere (ie Not Doing Anything) contractually.

Ask just moved to 20.7p

Was that really 100k sells I just saw pop up?

This is just so bizarre.

Well we've had Gerry on the Reuters panel and on Pro-Active and on The Sunday Roast all in quick succession and the shares keep getting sold down. MCAP now @£45m. with an SP of 21p. 21p I mean really? That's 2.1p in old SKIN money when the company had nothing like £10m incomes per annum.

This is what we know.

Helium Jul-21 524,000,000 8.6200%
Helium Mar-21 607,636,500 9.7700%
Helium Feb-21 722,500,000 11.8900%
Previously 13.1700%

So the know unknown is how many have they sold since July but given their previous sales volumes they seem to be selling down @100m per quarter so there could still be some way to go unless they decide that they will hold x amount and that is another known unknown here.

I did. Didn't really learn anything new apart from the China deal looks like it will take a bit longer yet. Bit of a love in if you ask me and I think Gerry got off lightly without having to address the elephant in the room.